5 matches for your search in the start-up spotlight
rss
Early detection of strokes and heart attacks
08-Apr-2025
An LMU team has developed a technology that can amplify the signals of biomarkers in conventional test strips more than a hundredfold. Now the researchers are commercializing the method. Since the Covid-19 pandemic, pretty much everybody is familiar with this technology: paper-based rapid test ...
LMU spin-off receives multi-million euro EU grant
24-Mar-2025
LMU scientist Olivia Merkel researches nanocarriers for the targeted delivery of drugs to their site of action. Now the company she co-founded, RNhale, has been awarded a lucrative EU grant to bring a new anti-asthma therapy to clinical readiness. The company name describes the envisioned product ...
In successful funding rounds, three LMU spin-offs have brought in investments worth millions.
25-Jun-2024
Tubulis, Smart Reporting, and Eisbach Bio have successfully attracted new investor funding. The new capital will enable the companies, for example, to expand their research and development activities. Tubulis and Eisbach develop new therapeutic approaches and active agents for cancer treatment, ...
Core Facility Animal Models and start-up company Iguana cooperate
17-Oct-2023
The Core Facility Animal Models (CAM) announces a new collaboration with drug discovery start-up Iguana Biotechnology GmbH (Iguana) to test their innovative vaccine candidate against Helicobacter pylori. Helicobacter pylori is one of the most common infectious diseases worldwide. It is a ...
12-Aug-2019
Treating cancer more selectively and more effectively – this could be achieved with an innovative technology developed by teams of researchers at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) and the Ludwig-Maximilians-Universität München (LMU). The process transforms proteins ...
